Authors:
de la Taille, A
Hayek, OR
Buttyan, R
Bagiella, E
Burchardt, M
Katz, AE
Citation: A. De La Taille et al., Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients, BJU INT, 84(7), 1999, pp. 845-850
Authors:
de la Taille, A
Olsson, CA
Buttyan, R
Bagiella, E
Cao, YC
Burchardt, T
Katz, AE
Citation: A. De La Taille et al., Columbia University experience of detection of circulating cells by RT-PCRPSA in prostate cancer as a predictive factor of stage and biochemical recurrence., PROG UROL, 9(3), 1999, pp. 555-561
Authors:
Petrylak, DP
Macarthur, RB
O'Connor, J
Shelton, G
Judge, T
Balog, J
Pfaff, C
Bagiella, E
Heitjan, D
Fine, R
Zuech, N
Sawczuk, I
Benson, M
Olsson, CA
Citation: Dp. Petrylak et al., Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 958-967
Authors:
de la Taille, A
Chen, MW
Shabsigh, A
Bagiella, E
Kiss, A
Buttyan, R
Citation: A. De La Taille et al., Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland, PROSTATE, 40(2), 1999, pp. 89-96
Authors:
Petrylak, DP
Macarthur, R
O'Connor, J
Shelton, G
Weitzman, A
Judge, T
England-Owen, C
Zuech, N
Pfaff, C
Newhouse, J
Bagiella, E
Hetjan, D
Sawczuk, I
Benson, M
Olsson, C
Citation: Dp. Petrylak et al., Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer, SEMIN ONCOL, 26(5), 1999, pp. 28-33
Authors:
de la Taille, A
Katz, A
Bagiella, E
Olsson, CA
O'Toole, KM
Rubin, MA
Citation: A. De La Taille et al., Perineural invasion on prostate needle biopsy: An independent predictor offinal pathologic stage, UROLOGY, 54(6), 1999, pp. 1039-1043
Authors:
Lee, N
Newhouse, JH
Olsson, CA
Benson, MC
Petrylak, DP
Schiff, PB
Bagiella, E
Malyszko, B
Ennis, RD
Citation: N. Lee et al., Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients, UROLOGY, 54(3), 1999, pp. 490-494
Authors:
Rubin, MA
Buyyounouski, M
Bagiella, E
Sharir, S
Neugut, A
Benson, M
de la Taille, A
Katz, AE
Olsson, CA
Ennis, RD
Citation: Ma. Rubin et al., Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome, UROLOGY, 53(3), 1999, pp. 542-547
Authors:
Sloan, RP
Shapiro, PA
Bagiella, E
Myers, MM
Gorman, JM
Citation: Rp. Sloan et al., Cardiac autonomic control buffers blood pressure variability responses to challenge: A psychophysiologic model of coronary artery disease, PSYCHOS MED, 61(1), 1999, pp. 58-68
Authors:
de la Taille, A
Rubin, MA
Bagiella, E
Olsson, CA
Buttyan, R
Burchardt, T
Knight, C
O'Toole, KM
Katz, AE
Citation: A. De La Taille et al., Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?, J UROL, 162(1), 1999, pp. 103-106
Authors:
De la Taille, A
Olsson, CA
Buttyan, R
Benson, MC
Bagiella, E
Cao, Y
Burchardt, M
Chopin, DK
Katz, AE
Citation: A. De La Taille et al., Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utilityof this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy, INT J CANC, 84(4), 1999, pp. 360-364
Authors:
McKiernan, JM
Buttyan, R
Bander, NH
de la Taille, A
Stifelman, MD
Emanuel, ER
Bagiella, E
Rubin, MA
Katz, AE
Olsson, CA
Sawczuk, IS
Citation: Jm. Mckiernan et al., The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9, CANCER, 86(3), 1999, pp. 492-497